- Report
- February 2023
- 200 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- January 2023
- 217 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- May 2022
- 61 Pages
Global
- Report
- September 2024
- 139 Pages
Global
From €2645EUR$2,999USD£2,290GBP
- Report
- January 2024
- 120 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- December 2023
- 120 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- May 2021
- 250 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Drug Pipelines
- November 2020
- 78 Pages
Global
From €3087EUR$3,500USD£2,672GBP
- Drug Pipelines
- July 2020
- 33 Pages
Global
From €3087EUR$3,500USD£2,672GBP
- Drug Pipelines
- February 2020
- 96 Pages
Global
From €3087EUR$3,500USD£2,672GBP
- Drug Pipelines
- January 2020
- 112 Pages
Global
From €3087EUR$3,500USD£2,672GBP
- Report
- October 2021
- 210 Pages
Global
From €3307EUR$3,750USD£2,863GBP
- Report
- November 2022
- 125 Pages
Global
From €2196EUR$2,490USD£1,901GBP
- Report
- April 2023
- 501 Pages
Global
From €4410EUR$5,000USD£3,817GBP
- Report
- April 2023
- 200 Pages
Global
From €4410EUR$5,000USD£3,817GBP
- Report
- February 2023
- 175 Pages
Global
From €4410EUR$5,000USD£3,817GBP
- Report
- September 2024
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- September 2024
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- June 2022
- 207 Pages
Global
From €2315EUR$2,625USD£2,004GBP
€4630EUR$5,250USD£4,008GBP
- Report
- May 2023
- 294 Pages
Global
From €4410EUR$5,000USD£3,817GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more